Evidence map›Paper›PMID 26972534›Full record

ReviewBrain research2016

Roles for RNA-binding proteins in development and disease.

Amy E Brinegar, Thomas A Cooper

Open access · greenAbstract readReview
In one paragraph

Review in Brain research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 2 syntheses or guidelines pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amy E BrinegarDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Thomas A CooperDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pathology and Immunology and Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: tcooper@bcm.edu.
Baylor College of Medicine · US

Funding

MOLECULAR PATHOGENESIS OF MYOTONIC DYSTROPHYR01AR045653 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 1999 to 2018
$8.3M
TROPONIN T ALTERNATIVE SPLICING IN EMBRYONIC HEARTR01HL045565 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 1996 to 2018
$5.5M
Transcriptome processing networks in skeletal muscle: mechanisms and functionsR01AR060733 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 2011 to 2023
$4.0M
Mechanisms of Developmentally Regulated SplicingR01GM076493 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 2006 to 2009
$1.1M
NHLBI NIH HHS R01 HL045565NIAMS NIH HHS R01 AR045653NIAMS NIH HHS R01 AR060733NIGMS NIH HHS R01 GM076493
6 · The paper itself

Abstract

RNA-binding protein activities are highly regulated through protein levels, intracellular localization, and post-translation modifications. During development, mRNA processing of specific gene sets is regulated through manipulation of functional RNA-binding protein activities. The impact of altered RNA-binding protein activities also affects human diseases in which there are either a gain-of-function or loss-of-function causes pathogenesis. We will discuss RNA-binding proteins and their normal developmental RNA metabolism and contrast how their function is disrupted in disease. This article is part of a Special Issue entitled SI:RNA Metabolism in Disease.

Indexed as

Growth and DevelopmentAmyotrophic Lateral SclerosisAnimalsBrainCELF1 ProteinCell NucleusDNA-Binding ProteinsHeartHumansMuscle, SkeletalMyocardiumMyotonic DystrophyRNARNA-Binding Protein FUSRNA-Binding ProteinsRNA, MessengerCELF1 ProteinDNA-Binding ProteinsFUS protein, humanMBNL1 protein, humanRNARNA-Binding Protein FUSRNA-Binding ProteinsRNA, MessengerTARDBP protein, humanDevelopmentNeurodegenerative diseaseProtein aggregateProtein mis-regulationRNA-binding proteinRNA processing

Identifiers

PMID26972534
PMCPMC5003702
OpenAlexW2295242434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.